International Patent: CD19 BINDING MOLECULES INCLUDING CD3- AND CD19- BISPECIFIC T CELL ENGAGERS AND RELATED METHODS AND USES

GENEVA, July 31 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/011895) for “CD19 BINDING MOLECULES INCLUDING CD3- AND CD19- BISPECIFIC T CELL ENGAGERS AND RELATED METHODS AND USES”. With publication no. WO/2026/161391, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61P 29/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....